Literature DB >> 25793271

Assessing Medicare Part D claim completeness using medication self-reports: the role of veteran status and Generic Drug Discount Programs.

Lei Zhou1, Sally C Stearns, Emily M Thudium, Khalid A Alburikan, Jo E Rodgers.   

Abstract

OBJECTIVE: Medicare Part D claims are commonly used for research, but missing claims could compromise their validity. This study assessed 2 possible causes of missing claims: veteran status and Generic Drug Discount Programs (GDDP).
MATERIALS AND METHODS: We merged medication self-reports from telephone interviews in the Atherosclerosis Risk in Communities (ARIC) Study with Part D claims for 6 medications (3 were commonly in GDDP in 2009). Merged records (4468) were available for 2905 ARIC participants enrolled in Part D. Multinomial logit regression provided estimates of the association of concordance (self-report and Part D, self-report only, or Part D only) with veteran and GDDP status, controlling for participant sociodemographics.
RESULTS: Sample participants were 74±5 years of age, 68% white and 63% female; 19% were male veterans. Compared with females, male veterans were 11% [95% confidence interval (CI), 7%-16%] less likely to have matched medications in self-report and Part D and 11% (95% CI, 7%-16%) more likely to have self-report only. Records for GDDP versus non-GDDP medications were 4% (95% CI, 1%-7%) more likely to be in self-report and Part D and 3% (95% CI, 1%-5%) less likely to be in Part D only, with no difference in self-report only.
CONCLUSIONS: Part D claims were more likely to be missing for veterans, but claims for medications commonly available through GDDP were more likely to match with self-reports. Although researchers should be aware of the possibility of missing claims, GDDP status was associated with a higher rather than lower likelihood of claims being complete in 2009.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25793271      PMCID: PMC4646610          DOI: 10.1097/MLR.0000000000000341

Source DB:  PubMed          Journal:  Med Care        ISSN: 0025-7079            Impact factor:   2.983


  18 in total

1.  Implications of the accuracy of MEPS prescription drug data for health services research.

Authors:  Steven C Hill; Samuel H Zuvekas; Marc W Zodet
Journal:  Inquiry       Date:  2011       Impact factor: 1.730

2.  Access to and use of $4 generic programs in Medicare.

Authors:  Yuting Zhang; Walid F Gellad; Lei Zhou; Yi-Jen Lin; Judith R Lave
Journal:  J Gen Intern Med       Date:  2012-02-07       Impact factor: 5.128

3.  Medicare Part D enrollees' use of out-of-plan discounted generic drugs.

Authors:  Bruce Stuart; F Ellen Loh; Ellen F Loh
Journal:  J Am Geriatr Soc       Date:  2012-02       Impact factor: 5.562

4.  Out-of-plan medication in Medicare Part D.

Authors:  Pamela N Roberto; Bruce Stuart
Journal:  Am J Manag Care       Date:  2014-09       Impact factor: 2.229

5.  Validity of reported Medicare Part D enrollment in the Medical Expenditure Panel Survey.

Authors:  Steven C Hill; Samuel H Zuvekas; Marc W Zodet
Journal:  Med Care Res Rev       Date:  2012-08-28       Impact factor: 3.929

6.  Self-reported adherence measures: what do they assess and how should we use them?

Authors:  John F Steiner
Journal:  Med Care       Date:  2012-12       Impact factor: 2.983

7.  Prevalence and predictors of utilization of community pharmacy generic drug discount programs.

Authors:  Justin Gatwood; Alexandra Tungol; Christopher Truong; Suzan N Kucukarslan; Steven R Erickson
Journal:  J Manag Care Pharm       Date:  2011 Jul-Aug

8.  Military combat and risk of coronary heart disease and ischemic stroke in aging men: The Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Anna M Johnson; Kathryn M Rose; Glen H Elder; Lloyd E Chambless; Jay S Kaufman; Gerardo Heiss
Journal:  Ann Epidemiol       Date:  2010-02       Impact factor: 3.797

9.  Generic drug discount programs: are prescriptions being submitted for pharmacy benefit adjudication?

Authors:  Alexandra Tungol; Catherine I Starner; Brent W Gunderson; Jeremy A Schafer; Yang Qiu; Patrick P Gleason
Journal:  J Manag Care Pharm       Date:  2012 Nov-Dec

10.  Data for drugs available through low-cost prescription drug programs are available through pharmacy benefit manager and claims data.

Authors:  Vivienne J Zhu; Anne Belsito; Wanzhu Tu; J Marc Overhage
Journal:  BMC Clin Pharmacol       Date:  2012-06-22
View more
  9 in total

1.  High health care costs in minority groups of older US Medicare beneficiaries with epilepsy.

Authors:  Maria Pisu; Joshua Richman; Jerzy P Szaflarski; Ellen Funkhouser; Chen Dai; Lucia Juarez; Edward Faught; Roy C Martin
Journal:  Epilepsia       Date:  2019-06-06       Impact factor: 5.864

2.  A Comparison of Self-reported Medication Adherence to Concordance Between Part D Claims and Medication Possession.

Authors:  Samuel T Savitz; Sally C Stearns; Lei Zhou; Emily Thudium; Khalid A Alburikan; Richard Tran; Jo E Rodgers
Journal:  Med Care       Date:  2017-05       Impact factor: 2.983

3.  Quality of Antiepileptic Treatment Among Older Medicare Beneficiaries With Epilepsy: A Retrospective Claims Data Analysis.

Authors:  Maria Pisu; Joshua Richman; Kendra Piper; Roy Martin; Ellen Funkhouser; Chen Dai; Lucia Juarez; Jerzy P Szaflarski; Edward Faught
Journal:  Med Care       Date:  2017-07       Impact factor: 2.983

4.  Incidence of and Risk Factors for Severe Adverse Events in Elderly Patients Taking Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers after an Acute Myocardial Infarction.

Authors:  Gang Fang; Izabela E Annis; Joel F Farley; Nirosha Mahendraratnam; Ryan P Hickson; Til Stürmer; Jennifer G Robinson
Journal:  Pharmacotherapy       Date:  2017-12-11       Impact factor: 4.705

5.  Agreement between Medicare pharmacy claims, self-report, and medication inventory for assessing lipid-lowering medication use.

Authors:  Lisandro D Colantonio; Shia T Kent; Meredith L Kilgore; Elizabeth Delzell; Jeffrey R Curtis; George Howard; Monika M Safford; Paul Muntner
Journal:  Pharmacoepidemiol Drug Saf       Date:  2016-01-29       Impact factor: 2.890

6.  Quantification of missing prescriptions in commercial claims databases: results of a cohort study.

Authors:  Maria Soledad Cepeda; Daniel Fife; Michel Denarié; Dan Bradford; Stephanie Roy; Yingli Yuan
Journal:  Pharmacoepidemiol Drug Saf       Date:  2017-01-25       Impact factor: 2.890

7.  It's Not Too Late to Improve Statin Adherence: Association Between Changes in Statin Adherence from Before to After Acute Myocardial Infarction and All-Cause Mortality.

Authors:  Ryan P Hickson; Jennifer G Robinson; Izabela E Annis; Ley A Killeya-Jones; Gang Fang
Journal:  J Am Heart Assoc       Date:  2019-04-02       Impact factor: 5.501

8.  Completeness of cohort-linked U.S. Medicare data: An example from the Agricultural Health Study (1999-2016).

Authors:  Christine G Parks; Srishti Shrestha; Stuart Long; Thomas Flottemesch; Sarah Woodruff; Honglei Chen; Gabriella Andreotti; Jonathan N Hofmann; Laura E Beane Freeman; Dale P Sandler
Journal:  Prev Med Rep       Date:  2022-03-15

9.  Changes in Statin Adherence Following an Acute Myocardial Infarction Among Older Adults: Patient Predictors and the Association With Follow-Up With Primary Care Providers and/or Cardiologists.

Authors:  Ryan P Hickson; Jennifer G Robinson; Izabela E Annis; Ley A Killeya-Jones; Maarit Jaana Korhonen; Ashley L Cole; Gang Fang
Journal:  J Am Heart Assoc       Date:  2017-10-19       Impact factor: 5.501

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.